866-997-4948(US-Canada Toll Free)

Post Menopausal Osteoporosis Global Clinical Trials Review, H2, 2016

Published By :

GlobalData

Published Date : Sep 2016

Category :

Clinical Trials

No. of Pages : 322 Pages

Post Menopausal Osteoporosis Global Clinical Trials Review, H2, 2016

Summary

GlobalData's clinical trial report, Post Menopausal Osteoporosis Global Clinical Trials Review, H2, 2016" provides an overview of Post Menopausal Osteoporosis clinical trials scenario. This report provides top line data relating to the clinical trials on Post Menopausal Osteoporosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Five Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Post Menopausal Osteoporosis to Metabolic Disorders Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Post Menopausal Osteoporosis to Metabolic Disorders Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Post Menopausal Osteoporosis Therapeutics Clinical Trials 27
Prominent Drugs 29
Latest Clinical Trials News on Post Menopausal Osteoporosis 30
Sep 18, 2016: Results From Phase 3 FRAME Study Of Romosozumab Showed Significant Reductions In Both New Vertebral And Clinical Fractures In Postmenopausal Women With Osteoporosis 30
Sep 18, 2016: Radius Announces Publication of Additional Positive Results from the Phase 3 ACTIVE Trial of Abaloparatide-SC in JBMR 31
Sep 14, 2016: Amgen to present romosozumab at Investor Call 32
Sep 07, 2016: UCB to present results from Phase 3 FRAME Study at the American Society for Bone and Mineral Research Annual Meeting 32
Aug 16, 2016: JAMA Publishes Positive Phase 3 Data for Abaloparatide in Postmenopausal Women With Osteoporosis 33
Jul 20, 2016: Radius Health Announces Multiple Presentations at the American Society for Bone and Mineral Research 2016 Annual Meeting September 16-19, 2016 34
Clinical Trial Profile Snapshots 35
Appendix 319
Abbreviations 319
Definitions 319
Research Methodology 320
Secondary Research 320
About GlobalData 321
Contact Us 321
Disclaimer 321
Source 322

List of Tables
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials by Region, 2016* 6
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Post Menopausal Osteoporosis Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 13
Proportion of Post Menopausal Osteoporosis to Metabolic Disorders Clinical Trials, G7 Countries (%), 2016* 14
Post Menopausal Osteoporosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Post Menopausal Osteoporosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Post Menopausal Osteoporosis to Metabolic Disorders Clinical Trials, E7 Countries (%), 2016* 17
Post Menopausal Osteoporosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Post Menopausal Osteoporosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials by Phase, 2016* 20
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Post Menopausal Osteoporosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29

List of Figures
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Post Menopausal Osteoporosis Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 12
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 13
Proportion of Post Menopausal Osteoporosis to Metabolic Disorders Clinical Trials, G7 Countries (%), 2016* 14
Post Menopausal Osteoporosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Post Menopausal Osteoporosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Post Menopausal Osteoporosis to Metabolic Disorders Clinical Trials, E7 Countries (%), 2016* 17
Post Menopausal Osteoporosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Post Menopausal Osteoporosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
Post Menopausal Osteoporosis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Post Menopausal Osteoporosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Post Menopausal Osteoporosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29
GlobalData Methodology 320

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *